CVE-2019-2413 — Vulnerability in the Oracle Reports Developer component of Oracle Fusion Middlew

Vulnerability in the Oracle Reports Developer component of Oracle Fusion Middleware (subcomponent: Valid Session). The supported version that is affected is 12.2.1.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracl

01What is this vulnerability?

Vulnerability in the Oracle Reports Developer component of Oracle Fusion Middleware (subcomponent: Valid Session). The supported version that is affected is 12.2.1.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Reports Developer. Successful attacks require human interaction from a person other than the attacker and while the…

02Affected products

Vendor	Product	Versions
n	a / n/a	n/a

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2019-01-16T19:00:00.000Z
• Last modified: 2024-10-02T16:21:37.101Z

09References

• www.securityfocus.com — http://www.securityfocus.com/bid/106603
• www.exploit-db.com — https://www.exploit-db.com/exploits/46187/
• www.oracle.com — http://www.oracle.com/technetwork/security-advisory/cpujan2019-5072801.html